XyloCor Therapeutics' Debt - IV Round

XyloCor Therapeutics raised a round of funding on July 26, 2018.

yloCor Therapeutics is a biopharmaceutical company developing gene therapy for people with advanced coronary artery disease.…

Articles about XyloCor Therapeutics' Debt - IV Round: